Cytosorbents (CTSO) Other Working Capital Changes (2010 - 2026)
Cytosorbents (CTSO) reported Other Working Capital Changes of $275148.0 for Q1 2026, up 691.09% on a YoY basis from $34781.0 in Q1 2025, and up 134.31% quarter-over-quarter from -$802000.0 in Q4 2025.
Cytosorbents (CTSO) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Cytosorbents has reported Other Working Capital Changes for 17 years, with the latest figure at $275148.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 691.09% year-over-year to $275148.0; the trailing twelve-month figure through Mar 2026 stood at $275148.0 (up 691.09% YoY), and the FY2025 full-year result was $373775.0, down 53.11% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $275148.0, up from -$802000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $1.6 million in Q4 2022, with the low at -$802000.0 in Q4 2025.
- Historically, Other Working Capital Changes has averaged $288514.2 across 5 years, with a median of $275148.0 in 2026.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes soared 174744.76% — and 2023, when it slumped 2365.62%.
- Cytosorbents' Other Working Capital Changes stood at $1.6 million in 2022, then tumbled by 83.35% to $266343.0 in 2023, then soared by 89.23% to $504000.0 in 2024, then plunged by 259.13% to -$802000.0 in 2025, then soared by 134.31% to $275148.0 in 2026.
- The last three Other Working Capital Changes figures came in at $275148.0 (Q1 2026), -$802000.0 (Q4 2025), and $908000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Cytosorbents | 28.80 Mn | 24.00 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 275,148.00 |
| Mar 31, 2026 | 275,148.00 |
| Dec 31, 2025 | -802,000.00 |
| Dec 31, 2025 | -802,000.00 |
| Sep 30, 2025 | 908,000.00 |
| Sep 30, 2025 | 908,000.00 |
| Jun 30, 2025 | 187,177.00 |
| Jun 30, 2025 | 187,177.00 |
| Mar 31, 2025 | 34,781.00 |
| Mar 31, 2025 | 34,781.00 |
| Dec 31, 2024 | 504,000.00 |
| Dec 31, 2024 | 504,000.00 |
| Sep 30, 2024 | 706,609.00 |
| Sep 30, 2024 | 706,609.00 |
| Jun 30, 2024 | 545,536.00 |
| Jun 30, 2024 | 545,536.00 |
| Mar 31, 2024 | 417,801.00 |
| Mar 31, 2024 | 417,801.00 |
| Dec 31, 2023 | 266,343.00 |
| Dec 31, 2023 | 266,343.00 |